Search

Your search keyword '"Ciombor, K.K."' showing total 11 results
Start Over Author "Ciombor, K.K."
11 results on '"Ciombor, K.K."'

1. Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)☆

Author

Cohen, R., Shi, Q., Meyers, J., Jin, Z., Svrcek, M., Fuchs, C., Couture, F., Kuebler, P., Ciombor, K.K., Bendell, J., De Jesus-Acosta, A., Kumar, P., Lewis, D., Tan, B., Bertagnolli, M.M., Philip, P., Blanke, C., O'Reilly, E.M., Shields, A., and Meyerhardt, J.A.

Published
2021
Full Text
View/download PDF

2. 361P Tucatinib plus trastuzumab in patients (Pts) with HER2-positive metastatic colorectal cancer (mCRC): Patient-reported outcomes (PROs) from ph II study MOUNTAINEER

Author

Wu, C., primary, Strickler, J.H., additional, Cercek, A., additional, Siena, S., additional, André, T., additional, Ng, K., additional, Van Cutsem, E., additional, Paulson, A.S., additional, Hubbard, J., additional, Coveler, A., additional, Fountzilas, C., additional, Kardosh, A., additional, Kasi, P.M., additional, Lenz, H.J., additional, Ciombor, K.K., additional, Elez Fernandez, M.E., additional, Hsu, L-I., additional, Stecher, M., additional, Zhao, K., additional, and Bekaii-Saab, T., additional

Published
2022
Full Text
View/download PDF

3. 354P NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302)

Author

Coveler, A., primary, Skolariki, A., additional, Ciombor, K.K., additional, Marijon Jourdier, H., additional, Graham, J., additional, Peters, M.L., additional, Cohen, S.A., additional, Myers, M., additional, Oelmann, E.M., additional, Bloss, J., additional, Blagden, S.P., additional, de Gramont, A., additional, Berlin, J.D., additional, and Evans, T.R.J., additional

Published
2022
Full Text
View/download PDF

4. LBA27 Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC

Author

Strickler, J.H., primary, Cercek, A., additional, Siena, S., additional, André, T., additional, Ng, K., additional, Van Cutsem, E., additional, Wu, C., additional, Paulson, A.S., additional, Hubbard, J., additional, Coveler, A., additional, Fountzilas, C., additional, Kardosh, A., additional, Kasi, P.M., additional, Lenz, H.J., additional, Ciombor, K.K., additional, Fernandez, M.E. Elez, additional, Bajor, D.L., additional, Stecher, M., additional, Feng, W., additional, and Bekaii-Saab, T., additional

Published
2022
Full Text
View/download PDF

5. 475P A phase Ib study of NUC-3373, a targeted inhibitor of thymidylate synthase, in combination with standard therapies in patients with advanced colorectal cancer (NuTide:302)

Author

Berlin, J., primary, Coveler, A.L., additional, Ciombor, K.K., additional, Kazmi, F., additional, Graham, J., additional, Peters, M.L., additional, Clark, J.W., additional, Myers, M., additional, De Gramont, A., additional, Evans, T.R.J., additional, and Blagden, S., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results